Back to Archived Journals » Research and Reports in Endocrine Disorders » Volume 2

Original Research

Sustained biochemical control in patients with acromegaly treated with lanreotide depot 120 mg administered every 4 weeks, or an extended dosing interval of 6 or 8 weeks: a pharmacokinetic approach

       
Total article views   HTML views PDF downloads Totals
12,279 Dovepress* 12,279+ 1,729 14,008
Totals 12,279 1,729 14,008
*Since 14 December 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on Google Scholar